Table 3.
Outcomes for young patients with urothelial tumorsa
| Noninvasive (n=31) | Invasive (n=10) | |||||
|---|---|---|---|---|---|---|
|
| ||||||
| PUNLMP (n = 2) | LGPUC (n = 26) | HGPUC (n = 3) | INVLP (n = 5) | INVMP (n = 4) | INVPS (n = 1) | |
| Mean follow-up time (range), months | 25 (13–37) | 71 (3–225) | 129 (37–238) | 85 (16–250) | 74 (15–166) | 10 |
| Alive with no recurrence | 2 | 16 | 1 | 2 | 0 | 0 |
| Alive with local recurrence | 0 | 9 | 1 | 0 | 0 | 0 |
| Alive with metastasis | 0 | 0 | 1 | 3 | 2 | 0 |
| Died of disease | 0 | 1b | 0 | 0 | 2 | 1 |
a
Follow-up information was available for 41 patients.
b
This patient later developed invasive high-grade urothelial carcinoma with metastasis and died after 160 months.
Abbreviations: PUNLMP, papillary urothelial neoplasm of low malignant potential; LGPUC, low-grade papillary urothelial carcinoma; HGPUC, high-grade papillary urothelial carcinoma, noninvasive; INVLP, urothelial carcinoma invading the lamina propria; INVMP, urothelial carcinoma invading the muscularis propria; INVPS, urothelial carcinoma invading the perivesical soft tissue.